Summary
IDEXX Laboratories, Inc. reported strong financial results for the nine months ended September 30, 2016, with total revenue increasing by 10.8% to $1.33 billion. This growth was primarily driven by the Companion Animal Group (CAG) segment, which saw a 12.0% revenue increase, highlighting sustained demand for veterinary diagnostics and services. Net income attributable to stockholders rose significantly to $169.7 million, up from $147.7 million in the prior year period, demonstrating improved profitability. The company also maintained a healthy cash flow from operations, providing flexibility for strategic investments and shareholder returns. The company's balance sheet reflects a solid financial position, with total assets growing and liabilities decreasing, leading to a substantial improvement in stockholders' equity. Cash and cash equivalents increased, bolstered by strong operating performance. IDEXX continues to manage its debt effectively, with a favorable debt-to-EBITDA ratio, indicating sound financial management and ample liquidity for ongoing operations and future growth initiatives.
Financial Highlights
51 data points| Revenue | $448.31M |
| Cost of Revenue | $201.58M |
| Gross Profit | $246.73M |
| R&D Expenses | $25.67M |
| Operating Income | $88.46M |
| Interest Expense | $7.79M |
| Net Income | $56.45M |
| EPS (Basic) | $0.63 |
| EPS (Diluted) | $0.62 |
| Shares Outstanding (Basic) | 89.89M |
| Shares Outstanding (Diluted) | 91.14M |
Key Highlights
- 1Total revenue for the nine months ended September 30, 2016, increased by 10.8% to $1.33 billion, compared to $1.20 billion in the prior year period.
- 2Net income attributable to IDEXX Laboratories, Inc. stockholders increased to $169.7 million for the nine months ended September 30, 2016, from $147.7 million in the prior year period.
- 3The Companion Animal Group (CAG) segment remains the primary growth driver, with revenue increasing by 12.0% to $1.14 billion for the nine months ended September 30, 2016.
- 4Operating cash flow for the nine months ended September 30, 2016, was robust at $234.5 million, a significant increase from $142.5 million in the prior year period.
- 5Total assets grew to $1.50 billion as of September 30, 2016, from $1.47 billion as of December 31, 2015, while total liabilities decreased from $1.56 billion to $1.45 billion.
- 6The company's effective income tax rate remained stable at approximately 30.7% for the nine months ended September 30, 2016.
- 7IDEXX continues to return value to shareholders, with share repurchases moderating in the current period compared to the prior year, alongside maintaining a strong debt leverage ratio.